Skip to content
OpenCapital
Get started

NXXT NXXT Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By product

See full
Fuel96.2%-1.3%

Other financials

Income statement

See full
Revenue$21.1M+29.4%
Gross profit$1.7M+230%
Operating income-$10.1M-75.4%
Net income-$10.7M-22.1%
EPS (diluted)-$0.07+95.6%

Balance sheet

See full
Cash & equivalents$208.0K-90.2%
Total debt$3.4M+4,849%
Total equity-$19.6M-252%
Total assets$12.3M-52.9%

Cash flow

See full
Operating cash flow-$2.1M+62.8%
CapEx$5.7M+26,892%
Free cash flow-$7.2M-490%

Valuation

See full
Market cap$55.34M-82.7%
Enterprise value$58.5M-81.6%
P/S0.6×-5.8×

Profitability

See full
Gross margin9.4%+4.4pp
Operating margin-86%-1,407pp
Net margin-101.1%+60.1pp
FCF margin-43%—

Returns & leverage

See full
Return on equity-1,208.8%-1,564pp
Debt / equity0.3×-56.1×
Current ratio0.2×0.0×